NEUROSCIENCE
XANA™ is a medical technology company that creates smart & non-invasive stimulators to modulate the activity of the brain.
Abnormal neuronal electrical signals are present in a wide range of disorders including anxiety and mood disorders, chronic pain, cardiological diseases, memory impairment and aging-related neurodegeneration, among many others.
The current pharmacological treatments don’t work as efficiently and safetly as desired. On the other hand, existing medical devices to stimulate the brain are emerging as tremendously powerful therapeutic tools that could revolutionize the treatment of brain diseases.
ENGINEERING
Unfortunately, existing devices to modulate brain activity by stimulation have serious handicaps. Invasiveness, low usability because of limited miniaturization, and the lack of personalization of the treatments hamper the adequate clinical effect and render these solutions unattractive for clinicians and patients.
XANA™ has demonstrated the capacity to change state-of-the-art microelectronics of today to create wireless neuro-devices with high levels of miniaturization, multi-site sensor/stimulator arrays and low power consumption, leading to lower risk, shorter recovery times, and better patient acceptance.
DIGITAL HEALTH
XANA™ takes advantage of all the potential of digital technologies to personalize treatments as well as to provide objective data about the efficacy of therapies.
The monitoring of both of the doses (stimulation charge) delivered as well as the real-time effect on the body allows the creation of unique neuromodulation systems.
We have developed and validated our own algorithm to measure the impact of the stimulation in the cardiological function.
This cardiological measurement, used in combination with other phsysiological indexes such as oxygen saturation and respiratory rate, offers doctors an exceptional tool for diagnosis, efficacy and adherence to the treatment.
Supported by
